RNATX 2025
The third Summit expanded the program with three keynotes, translational projects and career perspectives.
Keynote speakers
Mathias Vormehr
BioNTech · mRNA vaccines for cancer treatment
Annemieke Aartsma-Rus
University of Leiden · Exon skipping and N=1 treatments
Eric Miska
Storm Therapeutics & University of Cambridge · Targeting and delivering RNA
Program
Open a session to view its speakers and details.
08:00 Welcome coffee
08:45 Opening remarks
08:50 Keynote I · Mathias Vormehr
“mRNA vaccines for the treatment of cancer”
09:30 Company presentations I
Constance Ciaudo Beyer · DeepLife
Alice Ghidini · SENISCA
Dominik Witzigmann · NanoVation Therapeutics
10:30 The patent landscape of RNA therapeutics
Ingrid B. Müller · Swiss Federal Institute of Intellectual Property
10:40 Coffee break
11:35 Panel · RNA therapeutics: future developments
Marc Abramowicz · Jasmin Barman-Aksözen · Matias Wagner · Annemieke Aartsma-Rus · Mathias Vormehr
Moderator: Jonathan Hall
12:00 Lunch, poster session, networking & sponsor presentations
13:15 Lunch talk · Clement Quan
Alithea Genomics · “RNA sequencing at scale”
14:00 Keynote II · Annemieke Aartsma-Rus
“From Duchenne exon skipping to N=1 treatment”
14:40 Young scientists career talks
Alice Ghidini · Larissa Grolimund · Mateusz Mendel
15:00 Translational academic projects
Felix Baier · Algera Goga · Rory Johnson · Raja Prince
15:55 Coffee break
16:25 Company presentations II
Troels Koch · Covadonga Pañeda · Keith Phillips · Felix Schumacher
17:35 Keynote III · Eric Miska
“New ways of targeting and delivering RNA”
18:20 Apéro
Speakers & partners
Leading voices from academia, biotechnology and pharmaceutical development.
2025 sponsors
| Time | Session |
|---|---|
| 08:00 | Welcome Coffee |
| 08:45 | Opening Remarks – Organizer |
| 08:50 | Keynote I: Mathias Vormehr – Senior Director Cancer Vaccines, BioNTech “mRNA vaccines for the treatment of cancer” |
| 09:30 | Company Presentations I Constance Ciaudo Beyer — DeepLife — “Digital twin of cells for drug discovery” Alice Ghidini — SENISCA — “Oligonucleotide senotherapeutics for the diseases of ageing” Dominik Witzigmann — NanoVation Therapeutics — “Next-generation LNP technologies to enable RNA delivery beyond the liver” |
| 10:30 | Ingrid B. Müller — Swiss Federal Institute of Intellectual Property — “The Patent Landscape of RNA Therapeutics” |
| 10:40 | Coffee Break |
| 11:35 | Panel I – RNA Therapeutics: Future Developments Marc Abramowicz — Professor & Head, Genetic Medicine, University Hospital Geneva Jasmin Barman-Aksözen — Triemli Hospital & University of Zurich Matias Wagner — Institute of Human Genetics, Klinikum rechts der Isar, Technical University Munich Annemieke Aartsma-Rus — Professor of Human Genetics, University of Leiden Mathias Vormehr — Senior Director Cancer Vaccines, BioNTech Moderator: Jonathan Hall |
| 12:00 | Lunch, Poster Session, Networking & Sponsor Presentations |
| 13:15 | Lunch Talk — Clement Quan, Alithea Genomics — “RNA sequencing at scale: Next generation drug and biomarker discovery” |
| 14:00 | Keynote II — Annemieke Aartsma-Rus, Professor of Human Genetics, University of Leiden — “From Duchenne exon skipping to N=1 treatment: Applying lessons learned for (very) rare disease patients”r |
| 14:40 | Young Scientists Career Talks Alice Ghidini — VP Oligotherapeutics Development, SENISCA — “Bridging Chemistry and Preclinical Development of RNA Therapeutics, with a biophysical perspective” Larissa Grolimund — Global Regulatory Affairs CMC Manager, CSL Behring — “From RNA Lab to Regulatory Desk” Mateusz Mendel — Senior Scientist Lead Discovery, Roche — “From RNA Biology to Drug Discovery: Navigating an Early Career in Industry” |
| 15:00 | Translational Academic Projects |
| 15:55 | Coffee Break |
| 16:25 | Company Presentations II Troels Koch — MiNA Therapeutics — “MiNA therapeutics: Upregulating gene expression” Covadonga Pañeda — Altamira Therapeutics — “OligoPhore and SemaPhore for extrahepatic delivery of therapeutic RNA” Keith Phillips — Grünenthal — “New Horizons in RNA Therapeutics: Unlocking Peripheral Neuronal Delivery to Target Chronic Pain and Sensory Disorders” Felix Schumacher — Roche — “New developments in the delivery of therapeutic oligos to eye and brain” |
| 17:35 | Keynote III Eric Miska, Co-founder, Storm Therapeutics & University of Cambridge, United Kingdom — “New ways of targeting and delivering RNA” |
| 18:15 | Concluding Remarks – Carste Laue – Organizer |
| 18:20 | Apéro |
Gold Sponsors:
Roche – Doing what patients need next
Swiss Federal Institute of Intellectual Property
Bronze Sponsors:
Bern Economic Development Agency
Skyhawk Therapeutics – Small Molecules that Modify RNA Expression
Cygen – We Help You Discover Life
Booth sponsors:
Alithea Genomics – Large-scale RNA sequencing. For everyone
Microsynth – The Swiss DNA Company
Roche – Doing what patients need next
Swiss Federal Institute of Intellectual Property
Talk sponsors:
Coffee Break sponsors:
Speaker List
Let’s keep the conversation going.
Have a question about the Summit, registration or sponsorship? Get in touch with the RNATX team or follow us for the latest program announcements.